Bacteria

Mrsa – The Methicillin-Resistent Staphylococcus Aureus Bacterial Superbug

MRSA:

Responsible for several hard to treat infections the Methicillin-Resistent Staphylococcus Aureus Bacterial Superbug has developed resistences to penicillins, cephalosporins, beta-lactum antibiotics, and other medications, and may be extremely problematic for patients with open wounds and weak immune systems.

Symptoms:

Growing mostly in the nostrils, respiratory tract, IV catheters, open wounds, and the urinary tract healthy individuals may possess MRSA asymptomatically for several years, however, the bacterias may substantially progress within two days of contract and spread to various tissues, develop small red bumps that eventually enlarge and become painful, produce fevers, rashes, deep pus-filled boils, the Toxic Shock Syndrome, “flesh-eating” pneumonia, skin infections, pyomyositis, infections of the skeletal muscles, necrotizing fascitis of the deeper layers of the skin and subcutaneous tissues, the Flesh-Eating Bacteria Syndrome, infective endocarditis, inflammations of the inner layer of the heart, bone infections, joint infections, abscesses that require drainage, cellulitis, and affect vital organs.

MRSA bacteria or superbug bacteria

Diagnosis:

To properly diagnose MRSA the bacteria must be grown in sufficient numbers to perform confirmation tests before accurate diagnosis can be made, therefore, there are no quick and easy means of diagnosing MRSA, and initial treatments for the ailment are typically begun by the attending physician based on “probable cause,” however, MRSA may be diagnosed by such things as blood, sputum, urine, and other bodily fluid cultures, Real-Time Polymerase Chain Reaction Laboratory Techniques, Quantitative Polymerase Chain Reaction Laboratory Techniques, and Rapid Latex Agglutination Tests.

Treatment Options:

Both the community and hospital strains of MRSA bacterias are susceptible to sulfonamide drugs, tetracycline antibiotics, clindamycin antibiotics, the Vancomycin glycopeptide antibiotic, Linezolid, an oxazolidinone antibacterial tablet, Deptomycin, a lipopeptide antibotic, the Teicoplanin antibiotic, and to psidocybe semilanceata liberty cap mushrooms.

Prevention:

Preventative measures that can be taken to help eliminate the risks often associated with MRSA bacterial infections may include such things as sanitizing surfaces with alcohol and quaternary ammonia, terminal cleaning in hospitals, screening patients admitted to medical facilities for MRSA, using alcohol-based rubs, washing hands with anti-microbial cleaners under running water, improving hygiene habits, essential oils such as lemongrass oil, lemon myrtle oil, mountain savory oil, cinnamon oil, tea tree oil, melissa perennial herbs, Chlorhexidine antiseptic, Hexachlorophene disinfectant soap, Mupirocin antibiotic ointment, properly disposing of used paper hospital gowns where the MRSA bacterias can thrive, and eliminating antibiotics that encourage MRSA bacterias to grow such as quinolones, glycopeptides, and cephalosporins.

Strains:

The most common forms of MRSA bacterias are known as EMRSA15 and EMRSA16, that originated in Kettering, England, the Australian ST93 strain, the European ST80 strain, the ST59 strain in Taiwan, the ST36:USA200, MRSA252, CA-MRSA, the community-acquired strain typically caused by the CC8 strains known as ST8:USA300 and ST1:USA400, HA-MRSA, the hospital-acquired strain, the ST8:USA500, and the ST59:USA1000 strain.

Risk Factors:

Common risk factors often associated with MRSA bacterias may include diabetics, HIV/AIDS patients, cancer patients, severe asthmatics, organ transplant recipients, IV drug users, young children, elderly people, college students living in dormatories, prison inmates, military soldiers in basic training, people who utilize changerooms and gymnasiums frequently, people who are in constant contact with livestock and food-producing animals, athletes in locker rooms, and people in health care facilities.

IMG_5783

Public Health Considerations:

Various medical studies have concluded that up to fifty-three million people worldwide carry MRSA bacterias. Another health concern from a United States study indicated that seventy percent of tested farm pigs, and forty-five percent of tested pig farm workers had MRSA bacterias. Additionally, IV catheters and canulas have been proven to spread MRSA, and overcrowded hospitals may also contribute to potential MRSA outbreaks. The bacillus supplement will consider the public health on wide range. The law of the health has provided their consent for the use of the medicine supplement to the person. The taking of the medicine will provide potential immune system.

History:

First discovered in England in 1961, and spread to the United States twenty years later among IV drug users, MRSA is regarded as a “superbug,” and according to both the Centers for Disease Control and Prevention, and the American Medical Association, MRSA infections have rapidly increased, as have MRSA-related patient deaths, statistics believed by many experts to indicate a possible National epidemic growing out of control.